Low Implanted Second Trimester Placenta and Placenta Previa

Placenta Previa Clinical Trial

Official title:

The Prediction of Risk Factors of Progression of Low Implanted Placenta at 18- 24 Weeks to Placenta Previa at Term

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03431116
• Other study ID #: PPLIP
• Status: Completed
• Phase: N/A
• First received: February 7, 2018
• Last updated: February 7, 2018
• Start date: October 1, 2016
• Est. completion date: April 30, 2017

Study information

• Verified date: February 2018
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Placenta Previa is defined as a placenta implanted in the lower segment of the uterus, presenting ahead of the leading pole of the fetus (over or near the internal os). The prevalence of placenta previa has been estimated to be approximately 0.5% of all pregnancies, and this increase correlates to the elevated cesarean section rate . In Egypt, the prevalence of placenta previa is around 1.3% in Sohag Governorate and 1.5% in Aswan region according to.

Although various studies have tried to address risk factors associated with Placenta Previa development, the etiology of placenta previa still remains obscure. Several risk actors have been identified as strong contributors to placenta previa development. It is also a significant contributor to severe postpartum hemorrhage.Risk factors include; history of previous cesarean section, advanced maternal age, history of previous abortions, high parity and substance abuse during pregnancy (cigarette smoking), placental size (multiple pregnancy), endometrial damage (previous dilatation and curettage), uterine scars and pathology (previous myomectomy or endometritis), placental pathology (marginal cord insertions and succenturiate lobes), previous placental Previa, and curiously.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 52
• Est. completion date: April 30, 2017
• Est. primary completion date: March 30, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 45 Years

Eligibility

Inclusion Criteria:

1. Pregnant women between 18-24 weeks.

2. Diagnosed to have low implanted placenta by ultrasound

Exclusion Criteria:

1. Patient refused to follow-up in our setting.

2. Patient refused to perform Trans-vaginal ultrasound in the second trimester of gestation.

Related Conditions & MeSH terms

• Placenta Previa

Intervention

Radiation:
• ultrasound
to detect the placental site

Locations

Country	Name	City	State
Egypt	Women Health Hospital - Assiut university	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The distance between lower edge of the placenta and internal os by ultrasound (millimeter)		12 weeks